News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Mapping Brain Proteins
Devika G. Bansal | Feb 1, 2018
Researchers are using souped-up mass spectrometry to localize proteins within brain cells.
Virtual Reality May Revolutionize Brain Science
Ashley Yeager | Feb 1, 2018
New technology could open doors for researchers studying animals’ most complex organ.
“Retired” Mice Find New Life as Top Models for Autism
Jessica Wright | Jan 29, 2018
After years of obscurity, strains of mice with mutations in particular genes are thrust to the fore of autism research.
Book Excerpt from
Swearing is Good for You
Emma Byrne | Jan 23, 2018
In chapter 1, “The Bad Language Brain: Neuroscience and Swearing,” author Emma Byrne sets the scene for her book by telling the story of the hapless and potty-mouthed Phineas Gage.
EU Advisor Recommends Regulatory Exemption for Gene Editing
Catherine Offord | Jan 18, 2018
Crops produced using mutagenic technologies such as CRISPR should generally be exempt from regulatory laws governing GMOs, according to the published opinion.
Learning Opens the Genome
Ruth Williams | Jan 17, 2018
Researchers map learning-induced chromatin alterations in mouse brain cells, and find that many affect autism-associated genes.
Neurons Use Virus-Like Proteins to Transmit Information
Diana Kwon | Jan 15, 2018
In mice and flies, the Arc protein forms capsids and carries genetic information.
Long-Term Brain Rhythms Offer Possibility of Predicting Seizures
Diana Kwon | Jan 8, 2018
Researchers identify patterns of neural activity ranging from a few days to four weeks in individuals with epilepsy.
Primary Cilia in Neurons Linked to Obesity
Abby Olena | Jan 8, 2018
Three studies—one of mice and two of human genetics—describe the role of two proteins, adenylyl cyclase and melanocortin 4 receptor, in the development of obesity and diabetes.
Pfizer to Halt Alzheimer’s and Parkinson’s Drug Research
Jim Daley | Jan 7, 2018
The company’s recent effort to find new treatments for Alzheimer’s ended in disappointment.